Genetic Research Program

Genetic research improves the lives of men with prostate cancer.

What is genetic research?

Through our genetic research program, we’ve been able to make incredible progress in identifying different types of prostate cancer at diagnoses. Prostate cancer is a complex disease. Genetic research has the power to revolutionise the diagnosis, treatment and prognosis of each prostate cancer patient.

We are now able to deliver a world-leading, intensive genomic analysis of a large cohort of Australian men with high-risk disease.

The international projects we’re working on will deliver a number of outcomes that can significantly improve the care of men with lethal prostate cancer and yield new prognostic biomarkers which can discriminate between low risk and lethal disease.

The key: identify and differentiate between low-risk and high-risk disease

Our genetic research will lead to the development of tests to identify and differentiate between low-risk and high-risk prostate cancer. We will do this with participating clinical partners to allow the technology to be commercialised and accessed globally. The benefits for Australian men with lethal prostate cancer (and their families) will be that their care will significantly improve in the following ways:

  • A reduction in the number of men exposed unnecessarily to the potential morbidity of radical treatment without the realisation of any benefit gained.
  • Providing patients with access to state-of-the-art clinical trials as part of their patient journey. This gives the best chance to develop innovative state of the art treatments as well as valuable data for future research.
  • Optimal cancer care and treatment pathways for Australian men with aggressive prostate cancer to improve life expectancy and quality of life.
  • Individualised and customised treatment selection based on tumour profiling.

For all newly diagnosed Australian men with prostate cancer, 51% have no benefit from treatment and 17% die regardless of treatment. Genetic research can dramatically improve these numbers.

The discovery of new biomarkers will help us to identify low-risk cancer from high-risk cancer.

Research Projects

See All
PRECEPT

Improving methods of diagnosis treatment for individuals with potentially lethal prostate cancer.
Pan Prostate Cancer Group

As part of this global group we analyse genetic data from over 1800 men with prostate cancer.
Ironman Study

A global registry that collects information about men with advanced prostate cancer.
Survivorship Research

Identifying different types of prostate cancer and enabling targeted treatment.

Partner with us

Contact our research team at APC to find out how you can partner with us and get involved with our ground-breaking research.

Get in touch